OncoQuest Pharmaceuticals Inc (078590) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.019x

Based on the latest financial reports, OncoQuest Pharmaceuticals Inc (078590) has a cash flow conversion efficiency ratio of -0.019x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.42 Billion ≈ $-964.13K USD) by net assets (₩74.92 Billion ≈ $50.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of OncoQuest Pharmaceuticals Inc for the company's overall valuation and market capitalisation.

OncoQuest Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how OncoQuest Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

OncoQuest Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of OncoQuest Pharmaceuticals Inc ranked by their cash flow conversion efficiency. Explore 078590 cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Tunghsu Azure Renewable Energy Co Ltd SHE:000040	0.016x
VIVOPOWER INTL. DL -012 F:51J	N/A
Twinhead International Corp TW:2364	0.089x
SYN prop e tech S.A. SA:SYNE3	0.017x
MegaStudy Co. Ltd KQ:072870	0.041x
Gossamer Bio Inc NASDAQ:GOSS	0.439x
Star Holdings NASDAQ:STHO	-0.030x
Grange Resources Ltd AU:GRR	0.038x

Annual Cash Flow Conversion Efficiency for OncoQuest Pharmaceuticals Inc (2014–2025)

The table below shows the annual cash flow conversion efficiency of OncoQuest Pharmaceuticals Inc from 2014 to 2025. View 078590 stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩48.94 Billion ≈ $33.17 Million	₩485.35 Million ≈ $328.91K	0.010x	-88.00%
2024-12-31	₩47.92 Billion ≈ $32.47 Million	₩3.96 Billion ≈ $2.68 Million	0.083x	-67.92%
2023-12-31	₩43.42 Billion ≈ $29.43 Million	₩11.19 Billion ≈ $7.58 Million	0.258x	+3873.45%
2022-12-31	₩34.70 Billion ≈ $23.51 Million	₩-236.91 Million ≈ $-160.55K	-0.007x	+96.04%
2019-12-31	₩24.71 Billion ≈ $16.74 Million	₩-4.26 Billion ≈ $-2.89 Million	-0.172x	-413.09%
2018-12-31	₩26.14 Billion ≈ $17.71 Million	₩1.44 Billion ≈ $975.22K	0.055x	-80.11%
2017-12-31	₩17.32 Billion ≈ $11.73 Million	₩4.79 Billion ≈ $3.25 Million	0.277x	+11.73%
2016-12-31	₩14.30 Billion ≈ $9.69 Million	₩3.54 Billion ≈ $2.40 Million	0.248x	+6.21%
2015-12-31	₩11.98 Billion ≈ $8.12 Million	₩2.79 Billion ≈ $1.89 Million	0.233x	+63.10%
2014-12-31	₩7.10 Billion ≈ $4.81 Million	₩1.02 Billion ≈ $688.18K	0.143x	--

About OncoQuest Pharmaceuticals Inc

KQ:078590 Korea

Market Cap

$106.61 Million

₩157.31 Billion KRW

Market Cap Rank

#19063 Global

#920 in Korea

Share Price

₩2980.00

Change (1 day)

+1.02%

52-Week Range

₩1955.00 - ₩3725.00

All Time High

₩3725.00